Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 29 1 2021
medline: 15 12 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

Observational studies have suggested a link between fibromuscular dysplasia and spontaneous cervical artery dissection (sCeAD). However, whether patients with coexistence of the two conditions have distinctive clinical characteristics has not been extensively investigated. In a cohort of consecutive patients with first-ever sCeAD, enrolled in the setting of the multicenter IPSYS CeAD study (Italian Project on Stroke in Young Adults Cervical Artery Dissection) between January 2000 and June 2019, we compared demographic and clinical characteristics, risk factor profile, vascular pathology, and midterm outcome of patients with coexistent cerebrovascular fibromuscular dysplasia (cFMD; cFMD+) with those of patients without cFMD (cFMD-). A total of 1283 sCeAD patients (mean age, 47.8±11.4 years; women, 545 [42.5%]) qualified for the analysis, of whom 103 (8.0%) were diagnosed with cFMD+. In multivariable analysis, history of migraine (odds ratio, 1.78 [95% CI, 1.13-2.79]), the presence of intracranial aneurysms (odds ratio, 8.71 [95% CI, 4.06-18.68]), and the occurrence of minor traumas before the event (odds ratio, 0.48 [95% CI, 0.26-0.89]) were associated with cFMD. After a median follow-up of 34.0 months (25th to 75th percentile, 60.0), 39 (3.3%) patients had recurrent sCeAD events. cFMD+ and history of migraine predicted independently the risk of recurrent sCeAD (hazard ratio, 3.40 [95% CI, 1.58-7.31] and 2.07 [95% CI, 1.06-4.03], respectively) in multivariable Cox proportional hazards analysis. Risk factor profile of sCeAD patients with cFMD differs from that of patients without cFMD. cFMD and migraine are independent predictors of midterm risk of sCeAD recurrence.

Sections du résumé

BACKGROUND AND PURPOSE
Observational studies have suggested a link between fibromuscular dysplasia and spontaneous cervical artery dissection (sCeAD). However, whether patients with coexistence of the two conditions have distinctive clinical characteristics has not been extensively investigated.
METHODS
In a cohort of consecutive patients with first-ever sCeAD, enrolled in the setting of the multicenter IPSYS CeAD study (Italian Project on Stroke in Young Adults Cervical Artery Dissection) between January 2000 and June 2019, we compared demographic and clinical characteristics, risk factor profile, vascular pathology, and midterm outcome of patients with coexistent cerebrovascular fibromuscular dysplasia (cFMD; cFMD+) with those of patients without cFMD (cFMD-).
RESULTS
A total of 1283 sCeAD patients (mean age, 47.8±11.4 years; women, 545 [42.5%]) qualified for the analysis, of whom 103 (8.0%) were diagnosed with cFMD+. In multivariable analysis, history of migraine (odds ratio, 1.78 [95% CI, 1.13-2.79]), the presence of intracranial aneurysms (odds ratio, 8.71 [95% CI, 4.06-18.68]), and the occurrence of minor traumas before the event (odds ratio, 0.48 [95% CI, 0.26-0.89]) were associated with cFMD. After a median follow-up of 34.0 months (25th to 75th percentile, 60.0), 39 (3.3%) patients had recurrent sCeAD events. cFMD+ and history of migraine predicted independently the risk of recurrent sCeAD (hazard ratio, 3.40 [95% CI, 1.58-7.31] and 2.07 [95% CI, 1.06-4.03], respectively) in multivariable Cox proportional hazards analysis.
CONCLUSIONS
Risk factor profile of sCeAD patients with cFMD differs from that of patients without cFMD. cFMD and migraine are independent predictors of midterm risk of sCeAD recurrence.

Identifiants

pubmed: 33504192
doi: 10.1161/STROKEAHA.120.031579
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-829

Investigateurs

Rosario Pascarella (R)
Maria Sessa (M)
Emma Scelzo (E)
Monica Laura Bandettini di Poggio (ML)
Francesca Boscain (F)
Andrea Naldi (A)
Valeria Caso (V)
Massimo Gamba (M)
Ilaria Casetta (I)
Stefano Forlivesi (S)
Giampaolo Tomelleri (G)
Elena Schirinzi (E)
Elena Verrengia (E)
Graziamaria Nuzzaco (G)
Sandro Beretta (S)
Rossella Musolino (R)
Daniele Imperiale (D)
Maurizio Acampa (M)
Antonio Gasparro (A)
Maurizio Melis (M)
Francesco Fisicaro (F)
Ignazio Santilli (I)
Manuel Corato (M)
Marina Padroni (M)
Eleonora Leuci (E)
Federico Mazzacane (F)
Alessandra Gaiani (A)
Federica Assenza (F)
Lucia Princiotta Cariddi (LP)
Cristina Sarti (C)
Serena Monaco (S)
Emanuele Puca (E)
Ludovico Ciolli (L)

Auteurs

Sonia Bonacina (S)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Mario Grassi (M)

Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Unità di Statistica Medica e Genomica, Università di Pavia, Italy (M. Grassi).

Marialuisa Zedde (M)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Andrea Zini (A)

IRCCS Istituto di Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy (A.Z., M. Gentile).

Anna Bersano (A)

U.O. Malattie Cerebrovascolari, Fondazione IRCCS Istituto Neurologico "Carlo Besta," Milano, Italy (A.B.).

Carlo Gandolfo (C)

Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università di Genova, Italy (C.G.).

Giorgio Silvestrelli (G)

Dipartimento di Neuroscienze, Stroke Unit, Ospedale Carlo Poma, Mantova, Italy (G.S.).

Claudio Baracchini (C)

UOSD Stroke Unit e Laboratorio di Neurosonologia, Azienda Ospedale-Università di Padova, Italy (C.B.).

Paolo Cerrato (P)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Corrado Lodigiani (C)

Centro Trombosi, IRCCS Humanitas Research Hospital, Rozzano-Milano, Italy (C.L.).

Simona Marcheselli (S)

Neurologia d'Urgenza e Stroke Unit, IRCCS Humanitas Research Hospital, Rozzano-Milano, Italy (S.M.).

Maurizio Paciaroni (M)

Stroke Unit and Divisione di Medicina Cardiovascolare, Università di Perugia, Italy (M.P.).

Maurizia Rasura (M)

Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza," Roma, Italy (M.R.).

Manuel Cappellari (M)

Stroke Unit, Azienda Ospedaliera Universitaria Integrata Borgo Trento, Verona, Italy (M.C.).

Massimo Del Sette (M)

U.O. di Neurologia, Ospedale Galliera, Genova, Italy (M.D.S.).

Anna Cavallini (A)

UC Malattie Cerebrovascolari e Stroke Unit (A.C.), IRCCS Fondazione Istituto "C. Mondino," Pavia, Italy.

Andrea Morotti (A)

UO Neurologia, ASST della Valle Camonica, Esine, Italy (A.M.).

Giuseppe Micieli (G)

Neurologia d'Urgenza (G.M.), IRCCS Fondazione Istituto "C. Mondino," Pavia, Italy.

Enrico Maria Lotti (EM)

UOC Neurologia, AUSL Romagna, Ravenna, Italy (E.M.L.).

Maria Luisa DeLodovici (ML)

UO Neurologia, Ospedale di Circolo, Università dell'Insubria, Varese, Italy (M.L.D.).

Mauro Gentile (M)

IRCCS Istituto di Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italy (A.Z., M. Gentile).

Mauro Magoni (M)

Stroke Unit, Neurologia Vascolare, ASST Spedali Civili di Brescia, Italy (M. Magoni).

Cristiano Azzini (C)

U.O. di Neurologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria di Ferrara (C.A.).

Maria Vittoria Calloni (MV)

U.O. di Neurologia-Stroke Unit, Ospedale di Legnano, ASST-Ovest Milanese, Milano, Italy (M.V.C.).

Elisa Giorli (E)

Unità di Neurologia, Ospedale S. Andrea, La Spezia, Italy (E.G.).

Massimiliano Braga (M)

UOC Neurologia, ASST Vimercate, Italy (M.B.).

Paolo La Spina (P)

UOSD Stroke Unit, Dipartimento di Medicina Clinica e Sperimentale, Università di Messina, Italy (P.L.S.).

Fabio Melis (F)

SS NeuroVascolare Ospedale Maria Vittoria, ASL Città di Torino, Italy (F.M.).

Rossana Tassi (R)

UOC Stroke Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy (R.T.).

Valeria Terruso (V)

UO Neurologia, Ospedale Villa Sofia, Palermo, Italy (V.T.).

Rocco Salvatore Calabrò (RS)

Istituto di Ricovero e Cura a Carattere Scientifico, Centro Neurolesi Bonino-Pulejo, Messina, Italy (R.S.C.).

Valeria Piras (V)

SC Neurologia e Stroke Unit, Dipartimento Neuroscienze e Riabilitazione, Azienda Ospedaliera "G. Brotzu," Cagliari, Italy (V.P.).

Alessia Giossi (A)

UO Neurologia, Istituti Ospitalieri, ASST Cremona, Italy (A.G.).

Martina Locatelli (M)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Valentina Mazzoleni (V)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Debora Pezzini (D)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Sandro Sanguigni (S)

Dipartimento di Neurologia, Ospedale "Madonna del Soccorso," San Benedetto del Tronto, Italy (S.S.).

Carla Zanferrari (C)

UOC Neurologia-Stroke Unit, ASST Melegnano-Martesana, PO Vizzolo Predabissi, Italy (C.Z.).

Marina Mannino (M)

Stroke Unit, Ospedale Civico, Palermo, Italy (M. Mannino).

Irene Colombo (I)

S.C. Neurologia e Unità Neurovascolare, Ospedale di Desio-ASST Monza, Italy (I.C.).

Carlo Dallocchio (C)

Dipartimento di Area Medica, UOC Neurologia, ASST Pavia, Voghera, Italy (C.D.).

Patrizia Nencini (P)

Stroke Unit, Università degli Studi di Firenze, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy (P.N.).

Valeria Bignamini (V)

Stroke Unit, UO Neurologia, Ospedale "S. Chiara," Trento, Italy (V.B.).

Alessandro Adami (A)

Stroke Center, Dipartimento di Neurologia, IRCSS Sacro Cuore Negrar, Verona, Italy (A.A.).

Eugenio Magni (E)

UO Neurologia, Istituto Ospedaliero Poliambulanza, Brescia, Italy (E.M.).

Rita Bella (R)

Dipartimento Di Scienze Mediche e Chirurgiche e Tecnologie Avanzate, Sezione di Neuroscienze, Università di Catania, Italy (R.B.).

Alessandro Padovani (A)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Alessandro Pezzini (A)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica, Università degli Studi di Brescia, Italy (S.B., M.L., V.M., D.P., A. Padovani, A. Pezzini).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH